COMMUNIQUÉS West-GlobeNewswire

-
Medtronic Valiant(TM) Captivia(TM) Demonstrates Durability, Safety, and Efficacy at Five Years in Transection Patients
30/01/2019 -
HEXO Corp. closes C$57.5 million public offering of common shares
30/01/2019 -
HEXO Corp annonce la clôture de son offre publique d’actions ordinaires de 57,5 M $ CA
30/01/2019 -
Eve & Co Announces German Supply Agreement
30/01/2019 -
Sanofi: Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo
30/01/2019 -
Sanofi : Le fexinidazole, premier traitement entièrement par voie orale contre la maladie du sommeil, approuvé en République Démocratique du Congo
30/01/2019 -
Imprivata to Showcase Purpose-built Solutions for Healthcare at 2019 HIMSS Annual Conference
30/01/2019 -
CherryCircle Software Raises $2.3M to Advance QbDVision™ for Pharmaceutical Industry
30/01/2019 -
Relievant Announces Level I INTRACEPT Study Enrollment Stopped Early for Superiority
30/01/2019 -
NewLink Genetics to Participate in the Immuno-Oncology 360° Conference
30/01/2019 -
Konica Minolta Healthcare Releases Software Upgrade for SONIMAGE® HS1 Ultrasound System Featuring Improvements in Clinical Workflow and MSK Functionality
30/01/2019 -
Portola Pharmaceuticals to Present Full Results from the ANNEXA-4 Study of Andexxa During a Late-Breaking Oral Presentation at the International Stroke Conference 2019
30/01/2019 -
Medtronic Announces Positive Results from the Largest ENB Study to Aid in Lung Cancer Diagnosis, Staging, and Treatment Preparation in a Single Minimally Invasive Procedure
30/01/2019 -
Corvus Pharmaceuticals to Present Updated Biomarker and Clinical Data on Lead Development Programs CPI-444 and CPI-006 at Immuno-Oncology 360° Conference
30/01/2019 -
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2018 Results
30/01/2019 -
Assure Holdings Continues Expansion with New Partnership in Louisiana
30/01/2019 -
Kane Biotech Expands Previously-Announced Single Largest Order of bluestem™ Products
30/01/2019 -
IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT® NDA
30/01/2019 -
Neos Therapeutics Announces Appointment of James Robinson to Board of Directors
30/01/2019
Pages